Fierce Pharma Asia—Legend CEO’s cell therapy ambitions; Indian pharmas’ awkward position; new Hutchmed CEO aliu Fri, 03/11/2022 – […]
Month: March 2022
Calculating a person’s risk of developing prostate cancer using results from two blood markers would improve the accuracy […]
Skoltech researchers and their colleagues from HSE University and York University have presented an extensive dataset of indices […]
Listen“Listen to the patient; he is telling you the diagnosis.” I should be surprised if this aphorism has […]
The covid-19 pandemic has been exacerbated by underinvestment in public health, an “infodemic” of false or misleading information, […]
93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks […]
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory […]
If truth is the first casualty of war, the second is health and wellbeing. BMJ condemns Russia’s war […]
The government’s planned ‘Road to Recovery’ will have a new focus on prevention
Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days